|

SHR-A1811 combined with other antitumor therapies Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Jiangsu HengRui Medicine Co., Ltd.1

Indications

  • HER2-expressing Advanced Solid Tumors1
  • Cancer1

Other1 trial

A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.